Iowa HF802 expands the Right to Try Act to include individualized investigational treatments.

Iowa HF802 amends the Right to Try Act to include individualized investigational treatments, which are drugs, biological products, or devices unique to a patient based on their genetic profile. The bill defines "individualized investigational treatment" to include individualized gene therapy, antisense oligonucleotides, and individualized neoantigen vaccines. The Act allows eligible patients with terminal or life-threatening illnesses who have exhausted all other treatment options to access investigational treatments without FDA approval.

Iowa HF802 expands the Right to Try Act to include individualized investigational treatments.

Iowa HF802 amends the Right to Try Act to include individualized investigational treatments, which are drugs, biological products, or devices unique to a patient based on their genetic profile. The bill defines "individualized investigational treatment" to include individualized gene therapy, antisense oligonucleotides, and individualized neoantigen vaccines. The Act allows eligible patients with terminal or life-threatening illnesses who have exhausted all other treatment options to access investigational treatments without FDA approval.